Halozyme Therapeutics announces Roche (RHHBY) receives European Commission Approval of Tecentriq SC with ENHANZE (34.43)
Unfortunately, as much as we'd like to just go out and sell our services, we need some help on timing from the approval agencies. Need more of these to roll in.